Prepaid and other assets 6,963 49 (a) 7,012
Deferred tax asset 8,034 2,038 (b)(c)(f)(g) 10,072
Total current assets 347,990 1,300 349,290
Property and equipment, net 178,042 - 178,042
Intangible assets and
goodwill, net 72,955 - 72,955
Other assets 19,026 - 19,026
Total assets $618,013 $1,300 $619,313
Current liabilities:
Accounts payable $17,975 $- $17,975
Accrued liabilities 17,100 7,576 (b)(c)(d)(e) 24,676
(f)(g)
Current maturities of
long-term debt 1,681 - 1,681
Total current liabilities 36,756 7,576 44,332
Long-term debt 241,319 - 241,319
Other long-term liabilities 5,442 - 5,442
Deferred tax liabilities 25,221 - 25,221
Total liabilities 308,738 7,576 316,314
Commitments and contingencies - - -
Shareholders' equity:
Preferred stock - - -
Class A common stock 400 (3) (d) 397
Class B common stock 127 - 127
Additional paid-in capital 129,367 15,813 (b)(d) 145,180
Retained earnings 233,496 (22,086) (a)(b)(c)(e) 211,410
(f)(g)
Accumulated other
comprehensive loss (211
'/>"/>
| SOURCE KV Pharmaceutical Company Copyright©2008 PR Newswire. All rights reserved |